Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

NCT06653569 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

484

Enrollment

OTHER

Sponsor class

Conditions

Influenza Disease; Flu

Interventions

DRUG: Baloxavir Marboxil
DRUG: Placebo

Sponsor

Dre Pauline Vetter

Collaborators

Swiss National Science Foundation
University Hospital, Geneva
University of Geneva, Switzerland
Ente Ospedaliero Cantonale, Ticino, Switzerland
Centre Hospitalier Universitaire Vaudois (Switzerland)
University of Zurich
University Hospital, Zürich